1-9 of 9
Lucia Pantani, M.D.
Close
Sort by
Journal Articles

Clinical and Prognostic Relevance of Magnetic Resonance Imaging of the Spine in Newly Diagnosed Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation.

Patrizia Tosi, M.D., Alessandro Petrucci, M.D., Lucia Pantani, M.D., Elena Zamagni, Paola Tacchetti, M.D., Giulia Perrone, M.D., Annamaria Brioli, M.D., Michela Ceccolini, M.D., Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2009) 114 (22): 4885.
https://doi.org/10.1182/blood.V114.22.4885.4885
Published: 2009
Journal Articles

Thalidomide and Dexamethasone as Salvage Therapy after First Relapse in Multiple Myeloma: Analysis of Long-Term Outcomes.

Elena Zamagni, M.D., Alessandro Petrucci, M.D., Patrizia Tosi, M.D., Paola Tacchetti, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Maria Caterina Pallotti, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, MD
Journal: Blood
Blood (2009) 114 (22): 4933.
https://doi.org/10.1182/blood.V114.22.4933.4933
Published: 2009
Journal Articles

Thalidomide-Dexamethasone as Induction Therapy Prior to Autologous Stem-Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Failure.

Patrizia Tosi, M.D., Elena Zamagni, Paola Tacchetti, M.D., Michela Ceccolini, M.D., Giulia Perrone, M.D., Annamaria Brioli, M.D., Lucia Pantani, M.D., Alessandro Petrucci, M.D., Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2009) 114 (22): 4934.
https://doi.org/10.1182/blood.V114.22.4934.4934
Published: 2009
Journal Articles

A Phase III Study of Double Autotransplantation Incorporating Bortezomib-Thalidomide-Dexamethasone (VTD) or Thalidomide-Dexamethasone (TD) for Multiple Myeloma: Superior Clinical Outcomes with VTD Compared to TD.

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Sara Bringhen, M.D., Massimo Offidani, M.D., Franco Narni, M.D., Vittorio Montefusco, M.D., Elena Zamagni, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Claudia Cellini, M.D., Tommaso Caravita, M.D., Antonio Ledda, M.D., Antonietta Falcone, M.D., Patrizia Tosi, M.D., Chiara Nozzoli, M.D., Renato Zambello, M.D., Luciano Masini, M.D., Paola Agostini, M.D., Mauro Fiacchini, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2009) 114 (22): 351.
https://doi.org/10.1182/blood.V114.22.351.351
Published: 2009
Journal Articles

Incorporation of Thalidomide-Dexamethasone (Thal-Dex) into up-Front Double Autologous Stem-Cell Transplantation (ASCT) for multiple Myeloma: Final analysis of phase II “Bologna 2002” Study.

Elena Zamagni, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Paola Tacchetti, M.D., Chiara Nicci, B.S., Patrizia Tosi, M.D., Mauro Fiacchini, M.D., Francesca Patriarca, M.D., Francesco Di Raimondo, M.D., Lucio Catalano, M.D., Francesco Casulli, M.D., Silvestro Volpe, M.D., Luciano Masini, M.D., Antonio Ledda, M.D., Annamaria Brioli, M.D., Delia Cangini, M.D., Alessandro Gozzetti, M.D., Catello Califano, M.D., Claudia Cellini, M.D., Affra Carubelli, M.D., Alessandro Petrucci, M.D., Giuliana Leopardi, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Massimo Offidani, M.D., Giulia Perrone, M.D., Michele Baccarani, M.D., Michele Cavo, M.D.
Journal: Blood
Blood (2009) 114 (22): 349.
https://doi.org/10.1182/blood.V114.22.349.349
Published: 2009
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Superior Complete Response Rate and Progression-Free Survival after Autologous Transplantation with up-Front Velcade-Thalidomide- Dexamethasone Compared with Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma

Michele Cavo, M.D., Paola Tacchetti, M.D., Francesca Patriarca, M.D., Maria Teresa Petrucci, M.D., Lucia Pantani, M.D., Michela Ceccolini, M.D., Monica Galli, M.D., Francesco Di Raimondo, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Franco Narni, M.D., Sara Bringhen, M.D., Vittorio Montefusco, M.D., Massimo Offidani, M.D., Silvia Buttignol, M.D., Anna Levi, M.D., Ausilia Gorgone, M.D., Annamaria Brioli, M.D., Maria Caterina Pallotti, M.D., Tonino Spadano, M.D., Norbert Pescosta, M.D., Luca Baldini, M.D., Antonio Ledda, M.D., Tommaso Caravita, M.D., Antonietta Falcone, M.D., Alfonso Zaccaria, M.D., Giulia Perrone, M.D., Alessandro Petrucci, M.D., Antonio Palumbo, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 158.
https://doi.org/10.1182/blood.V112.11.158.158
Published: 2008
Journal Articles

Bortezomib (Velcade®)-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) in Preparation for Autologous Stem-Cell (SC) Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (MM).

Michele Cavo, MD, Francesca Patriarca, M.D., Paola Tacchetti, M.D., Monica Galli, M.D., Giulia Perrone, M.D., Maria Teresa Petrucci, M.D., Annamaria Brioli, M.D., Sara Bringhen, M.D., Lucia Pantani, M.D., Patrizia Tosi, M.D., Claudia Crippa, M.D., Elena Zamagni, M.D., Francesco Di Raimondo, M.D., Franco Narni, M.D., Claudia Cellini, M.D., Michela Ceccolini, M.D., Norbert Pescosta, M.D., Maria Cecilia Goldaniga, M.D., Vittorio Montefusco, M.D., Vincenzo Callea, M.D., Valerio De Stefano, M.D., Tommaso Caravita, M.D., Mario Boccadoro, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 73.
https://doi.org/10.1182/blood.V110.11.73.73
Published: 2007
Journal Articles

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Michele Cavo, MD, Giulia Perrone, M.D., Michela Ceccolini, M.D., Vito Michele Lauta, M.D., Massimo Offidani, M.D., Filippo Ballerini, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Silvana Pasini, M.D., Fausto Dore, M.D., Domenico Vertone, M.D., Paola Tacchetti, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Sante Tura, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 730.
https://doi.org/10.1182/blood.V110.11.730.730
Published: 2007